Enamel Remineralization Potential of Dentifrices in Situ
NCT ID: NCT01128946
Last Updated: 2015-01-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
83 participants
INTERVENTIONAL
2009-11-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model
NCT00752089
Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions
NCT01641237
Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes
NCT00708305
In Situ Caries Model of Fluoride Toothpastes
NCT01005966
In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste
NCT03296072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluoride Toothpaste 1
Fluoride toothpaste containing sodium fluoride (NaF)
NaF
Fluoride toothpaste containing sodium fluoride as 1450 parts per million (ppm) F, 675 ppmF, 450 ppmF, 350ppmF.
Fluoride Toothpaste 2
Fluoride toothpaste containing stannous fluoride (SnF) and NaF.
NaF
Fluoride toothpaste containing sodium fluoride as 1450 parts per million (ppm) F, 675 ppmF, 450 ppmF, 350ppmF.
SnF
Fluoride toothpaste containing stannous fluoride (1100 ppmF)
Fluoride Toothpaste 3
Fluoride toothpaste containing sodium monofluorophosphate (NaMFP) and NaF.
NaF
Fluoride toothpaste containing sodium fluoride as 1450 parts per million (ppm) F, 675 ppmF, 450 ppmF, 350ppmF.
NaMFP
Fluoride toothpaste containing sodium monofluorophosphate (1000 ppmF)
Reference Dentifrice
Low fluoride toothpaste containing NaF
NaF
Fluoride toothpaste containing sodium fluoride as 1450 parts per million (ppm) F, 675 ppmF, 450 ppmF, 350ppmF.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NaF
Fluoride toothpaste containing sodium fluoride as 1450 parts per million (ppm) F, 675 ppmF, 450 ppmF, 350ppmF.
SnF
Fluoride toothpaste containing stannous fluoride (1100 ppmF)
NaMFP
Fluoride toothpaste containing sodium monofluorophosphate (1000 ppmF)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No current active caries or periodontal disease that may compromise the study or health of the subject.
* All restorations in a good state of repair
* Currently wearing a removable mandibular partial denture with sufficient room in the posterior buccal flange area to accomodate two enamel specimens required dimensions 12 x 7 mm.
* Willing to have their denture modified to accomodate enamel test specimens
* Willing and capable of wearing removable mandibular partial dentures 24 hours per day during the treatment periods.
* Salivary flow rate in the range of normal values (unstimulated whole saliva flow rate greater than or equal to 0.2 mL/ minute; gum base stimulated whole saliva flow rate greater than or equal to 0.8 mL/minute.
Exclusion Criteria
* Current active caries or periodontal disease that may compromise the study or health of the subject.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University School of Dentistry
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T3500690
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.